Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Biochem ; 150(3): 303-10, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21558327

ABSTRACT

The phorbol ester tetradecanoylphorbol acetate (TPA) induces promyelocytic leukaemia cells to differentiate to macrophage-like cells in vitro. During the course of this differentiation, the cells adhere to the bottom of the culture dish, a process that requires an increase in cell surface glycosphingolipids (GSLs). We examined the cellular content of glucosylceramide (GlcCer), the simplest of the GSLs, in a TPA-treated leukaemia cell line, U937. Following TPA treatment, we observed a 3.5-fold increase in GlcCer levels that was caused by enhanced activity of ceramide glucosyltransferase (GlcT-1), which catalyses ceramide glycosylation. Furthermore, in TPA-treated cell GlcT-1 amounts were increased at both the mRNA and protein levels. We also found decreased activity of lactosylceramide synthase in TPA-treated cells, which could also contribute to the increase in cellular GlcCer content.


Subject(s)
Glucosylceramides/metabolism , Glucosyltransferases/metabolism , Cell Adhesion , Cell Differentiation/drug effects , Cell Line, Tumor , Galactosyltransferases/metabolism , Humans , Leukemia/enzymology , Leukemia/pathology , Macrophages/pathology , RNA, Messenger/metabolism , Tetradecanoylphorbol Acetate/pharmacology , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...